MYCN degraders Nurix Therapeutics

N/A

Report date: 2025/03/20 16:03:39
NME

Base Information

Drug NameMYCN degraders Nurix Therapeutics
Drug Alias NameN-myc proto-oncogene protein degraders Nurix Therapeutics
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN-myc proto-oncogene protein inhibitors
TargetsN-myc proto-oncogene protein
Therapy Area/IndicationsNeuroblastomaMedulloblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNurix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNurix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeuroblastomaMedulloblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A